Is REGENXBIO Inc. (RGNX) a Buy, Sell, or Hold?
REGENXBIO Inc.
NASDAQ:RGNX
$12.29 USD
-$0.46 (-3.61%)
- Volume
- 1.57M
- Average Volume
- 1.95M
- Market Capitalization
- $635.36M
- P/E Ratio
- -2.19
- Dividend Yield
- 0.00%
- Price Target
- $18.00
- Year High
- $16.19
- Year Low
- $5.46
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.62
Analyst Rating
Strong Sell
1 Rating Score
UPSIDE/DOWNSIDE
-31.7% DOWNSIDE
$18.00 Price Target
UPSIDE/DOWNSIDE HIGH
-61.6% DOWNSIDE
$32.00 Price Target High
UPSIDE/DOWNSIDE LOW
2.4% UPSIDE
$12.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Yi Chen | $26 | $11.98 | 2026-07-01 07:00 AM | 117.0% |
| Leerink Partners | Mani Foroohar | $18 | $8.88 | 2026-06-22 10:21 AM | 102.7% |
| Robert W. Baird | Brian Skorney | $32 | $8.9112 | 2026-06-22 09:50 AM | 259.1% |
| Barclays | Eliana Merle | $12 | $6.245 | 2026-05-15 05:00 AM | 92.2% |
| Morgan Stanley | Judah Frommer | $17 | $8.72 | 2026-03-05 02:52 PM | 95.0% |
| Robert W. Baird | Brian Skorney | $27 | $8.92 | 2026-02-10 08:50 AM | 202.7% |